Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874) has provided supplementary financial information regarding its acquisition of an 11.04% equity interest in a target company. According to audited figures for the fiscal year ended 31 December 2024 and unaudited data as of 30 June 2025, the target company’s equity book value was approximately RMB7.79 billion and RMB7.85 billion, respectively. The portion attributable to the acquired shares reached roughly RMB859.78 million as of last year-end and RMB867.08 million by mid-2025.

The seller, AHAPL, was previously under Walgreens Boots Alliance, Inc. (WBA), which underwent privatization involving Sycamore Partners and Stefano Pessina, leading to WBA’s delisting from Nasdaq. AHAPL is now wholly owned by Blazing Star Investors, LLC, the post-restructuring holding entity of that group. Guangzhou Baiyunshan noted that, to its knowledge, AHAPL and its ultimate owners are third parties independent of the company and its connected persons.

All other details in the original announcement remain unchanged, with the new information adding clarity on the transaction’s financial background and the seller’s corporate restructuring.